// App-Quantinova.ai

AB0295 (2021) : TREATMENT OF HIGH RISK/REFRACTORY OBSTETRIC ANTIPHOSPHOLIPID SYNDROME. A SINGLE CENTRE EXPERIENCE

Researchers

Presenter

  • A. Hoxha

Principal Investigators

  • P. Marson

  • M. Favaro

  • M. Tonello

  • M. Zen

  • T. Del Ross

  • A. Calligaro

  • A. Ruffatti

Medical Centers

  • San Bortolo Hospital, Department of Neurosciences, Vicenza, Italy

  • University-Hospital of Padua, Padua, Italy, Apheresis Unit, Blood Transfusion Service, Padua, Italy

  • University Hospital of Padua, Padua, Italy, Department of Medicine, Rheumatology Unit, Padua, Italy

  • University Hospital of Padua, Padua, Italy, Department of Medicine, Rheumatology Unit, Padua, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

Disease

  • Antiphospholipid syndrome

  • Venous thrombosis

  • Lupus

Biomarkers

  • Immunoglobulin G

Drug/Treatment

  • Aspirin

  • Albyl-E

  • Heparin

Outcome

  • N/A

Study Design

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved